IOVA

Iovance Biotherapeutics
IOVA

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.05B
EV
$780.41M
Shares Outstanding
327.88M
Beta
1.04

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$19.18
P/E 2025E
-
P/Revenue 2025E
2.31x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Iovance Biotherapeutics, Inc.

gainify
IOVA

Iovance Biotherapeutics, Inc.

IOVA

Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company ...

Sector

Healthcare

Industry

Biotechnology

CEO

Vogt, Frederick

Employees

838

IPO Date

2010-10-15

Headquarters

825 Industrial Road, Suite 400, San Carlos, California, 94070, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved